Insights

Perspectives from the field

Essays from the HS Foundation board and the guidelines workgroup on what the guidelines change, what they do not, and what comes next.

HS Is a Systemic Disease. The Evidence Base Has to Reflect That.

For years HS was treated as a skin disease, but large-scale data now show it touches nearly every organ system. That changes how clinicians choose treatment and how payers weigh its cost, and it raises the bar for the evidence the field needs to build.

Amit Garg, MD — Secretary, HS Foundation

Haley B. Naik, MD

Guidelines Are a First Step. The Harder Work Comes Next.

Haley B. Naik, MD — President, HS Foundation

Christopher Sayed, MD

There Was No Playbook for HS Care. There Is One Now.

Christopher Sayed, MD — Vice President, HS Foundation; Professor of Dermatology, University of North Carolina at Chapel Hill

Steven Daveluy, MD

The First Doctor an HS Patient Sees Is Usually Not a Dermatologist.

Steven Daveluy, MD — Professor of Dermatology, Wayne State University

Brent Hazelett, MPA, CAE

HS Care Has Outgrown Its Standards. The Field Is Catching Up.

Brent Hazelett, MPA, CAE — Chief Executive Officer, The HS Foundation

Where to go next

The recommendations themselves

All 37, searchable, with strength and certainty.

Open the Guideline Finder

Work through the guidelines

Four modules, about an hour.

Hidradenitis Suppurativa Foundation
is a 501(c)(3) nonprofit organization

© Copyright 2026 HS Foundation.

Terms & Privacy